Literature DB >> 81673

Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas.

G Y Gillespie, C B Hansen, S W Russell.   

Abstract

We have previously documented the development and subsequent disappearance of cytolytic activity mediated by lymphocytes from lymph nodes draining Moloney sarcomas destined either to regress or grow progressively. We now report that these tumour-draining lymphnode cells (LNC) that were no longer cytotoxic, spontaneously regenerated peak levels of killing after culture in vitro for 4 days in the absence of exogenous tumour antigen. Cytolytic activity, which was antigenically specific, was mediated by T lymphocytes. Resurgence of cytolytic activity in vitro was accompanied by proliferative changes (DNA synthesis, blast transformation, cell division) which peaked on the 3rd day of culture. Although normal, nonimmune LNC underwent quantitatively similar proliferative changes in culture, the killing that developed was weak and antigenically nonspecific. Transfer of cultured, tumour-draining LNC to immunologically compromised, syngeneic mice conferred complete protection from Moloney sarcoma progression. Adoptive transfer could be delayed for 6 days after tumour induction without loss of protection. These results suggest that there exists in Moloney sarcoma-bearing mice a mechanism that limits the differentiation of pre-killer cells into cytolytically active T lymphocytes, and that such inhibition is eliminated when LNC are explanted into culture.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81673      PMCID: PMC2009749          DOI: 10.1038/bjc.1978.216

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Studies on the distribution and origin of cytolytic T lymphocytes present in mice bearing Moloney murine sarcoma virus (MSV)-induced tumors.

Authors:  F Plata; H R MacDonald; B Sordat
Journal:  Bibl Haematol       Date:  1975-10

2.  Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

3.  Studies on T cell clonal expansion. II. The in vitro differentiation of pre-killer and memory T cells.

Authors:  R Kamat; C S Henney
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

4.  Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression.

Authors:  S W Russell; G Y Gillespie; C B Hansen; C G Cochrane
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

5.  Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.

Authors:  H T Holden; J S Haskill; H Kirchner; R B Herberman
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

6.  In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes.

Authors:  A Starzinski-Powitz; K Pfizenmaier; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

7.  Participation of three lymphoid cell types in the in vitro activation of cell-mediated immunity to a syngeneic gross virus-induced lymphoma in rats.

Authors:  J Y Djeu; M Glaser; K Y Huang; R B Herberman
Journal:  Cell Immunol       Date:  1976-05       Impact factor: 4.868

8.  Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.

Authors:  O Kuperman; G W Fortner; Z J Lucas
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

9.  Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells.

Authors:  S W Russell; W F Doe; R G Hoskins; C G Cochrane
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

10.  Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Authors:  M Röllinghoff; A Starzinski-Powitz; K Pfizenmaier; H Wagner
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.